http://www.akebia.com
Akebia Therapeutics, Inc. Company Intro
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Industry
Healthcare
Akebia Therapeutics, Inc. Headquaters
245 First Street
Cambridge,02142
United States
Akebia Therapeutics, Inc. Share price
14 Sep 2022 08:34 GMT
$0.4100
-0.01 (-3.16 %)
Akebia Therapeutics, Inc. Market cap
$71.333 M
WMC RANKING
2023
Akebia Therapeutics, Inc. # 34
BiotechnologyLatest Akebia Therapeutics, Inc. News
26 Jan 2023
Akebia Therapeutics Inc. (AKBA) Is Sitting On A Potential Gold ...
Akebia Therapeutics Inc. (NASDAQ:AKBA) concluded the trading at $0.71 on Wednesday, January 25 with a fall of -1.44% from its closing price on previous day.
26 Jan 2023
Akebia Therapeutics Inc. (AKBA) Is Sitting On A Potential Gold ...
Akebia Therapeutics Inc. (NASDAQ:AKBA) concluded the trading at $0.71 on Wednesday, January 25 with a fall of -1.44% from its closing price on previous day.
26 Jan 2023
Akebia Therapeutics Inc. (AKBA) Is Sitting On A Potential Gold ...
Akebia Therapeutics Inc. (NASDAQ:AKBA) concluded the trading at $0.71 on Wednesday, January 25 with a fall of -1.44% from its closing price on previous day.
WMC Market Score
WMC Market to Revenue Score
Akebia Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Akebia Therapeutics, Inc. | USD | $259,133 | $338,585 | $-392,290 | $713M | 34 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Akebia Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. Post vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Akebia Therapeutics, Inc. | 2.82 | 11.69 | 0.11 | 0 | 0 | 0 | 5.34 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
